Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.86
-0.03 (-0.44%)
At close: May 29, 2025, 4:00 PM
6.87
+0.01 (0.15%)
After-hours: May 29, 2025, 4:04 PM EDT
Kamada Revenue
Kamada had revenue of $44.02M in the quarter ending March 31, 2025, with 16.65% growth. This brings the company's revenue in the last twelve months to $167.24M, up 11.83% year-over-year. In the year 2024, Kamada had annual revenue of $160.95M with 12.93% growth.
Revenue (ttm)
$167.24M
Revenue Growth
+11.83%
P/S Ratio
2.35
Revenue / Employee
$398,179
Employees
420
Market Cap
393.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
KMDA News
- 15 days ago - Kamada Ltd. (KMDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability - GlobeNewsWire
- 2 months ago - Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas - GlobeNewsWire
- 3 months ago - Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth - GlobeNewsWire
- 3 months ago - Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025 - GlobeNewsWire
- 4 months ago - Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America - GlobeNewsWire
- 7 months ago - Kamada Ltd. (KMDA) Q3 2024 Earnings Call Transcript - Seeking Alpha